Quantcast

Latest Lupus Stories

2011-03-09 17:26:00

First new lupus drug approved in 56 years SILVER SPRING, Md., March 9, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Benlysta is delivered...

2011-03-09 17:25:00

WASHINGTON, March 9, 2011 /PRNewswire/ -- Today, the U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/lupus/48747/ (Photo: http://photos.prnewswire.com/prnh/20110309/MM58624 ) Sandra C. Raymond, President and Chief Executive Officer of the Lupus Foundation of America (LFA), has issued the...

2011-03-09 14:22:00

Alliance For Lupus Research Commits $500,000 To Glean Genetic Basis For Lupus In African Americans And Other Ethnicities Powerful ImmunoChip Technology Expands Range of Testing NEW YORK, March 9, 2011 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) - the world's largest private funder of lupus research - today announced funding of an important new study to identify lupus susceptibility genes in multiple ethnicities including African Americans, who are three times more...

092fc1f823fd1b4d2ac75d740adcb9d71
2011-03-08 07:25:00

A drug for lupus, produced by Human Genome Sciences Inc., is set to get clearance from health regulators, bringing patients the first approved treatment in more than 50 years, and potentially bringing heavy revenue to the company. Analysts expect the Food and Drug Administration to approve Benlysta by Thursday. If approved, global sales could top $3 billion in 2015, according to Thomson Reuters consensus forecasts. The company will split Benlysta profits with partner GlaxoSmithKline Plc....

2011-02-04 01:04:17

Researchers at Dana-Farber Cancer Institute in Cambridge, Mass., in collaboration with Jackson Laboratory scientists, have identified a regulatory defect that drives lupus. Correcting the defect "may represent an effective therapeutic approach to systemic lupus erythematosus-like autoimmune disease," the researchers state in their research paper, published in the Proceedings of the National Academy of Sciences. The research team was led by Harvey Cantor, M.D., chair of the department of...

2011-02-01 16:18:56

Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring. Rujuan Dai, research scientist, and her colleagues in the veterinary college's Department of Biomedical Sciences and Pathobiology, have discovered a "common set...

2011-01-27 14:24:50

Activation of interferon signaling pathway may cause premature plaque build-up Researchers in China have demonstrated interferon-alpha (IFN-a) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-a priming was shown to promote lipid uptake and foam cell formation"”a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE. Full...

2010-12-31 12:20:16

(Ivanhoe Newswire) "“ A new study provides insight into the underlying pathology associated with the autoimmune disease, systemic lupus erythematosus (SLE). The research shows an unexpected role for a key type of immune cell could provide a potential new therapeutic strategy for SLE and, possibly, other autoimmune diseases. SLE is a chronic systemic disease that can affect many regions of the body and, as a result, presents with diverse clinical symptoms. As is characteristic of other...

2010-12-23 13:30:00

Lupus Foundation of America Highlights the Year's Top Ten Achievements WASHINGTON, Dec. 23, 2010 /PRNewswire-USNewswire/ -- Events of 2010 represented the beginning of the long anticipated transition to a new era in which the 1.5 million Americans and the more than five million individuals worldwide living with the autoimmune disease lupus can look forward to an improved quality of life. Potential new treatments for lupus passed several milestones on the road toward approval, public and...

2010-12-14 15:15:00

HAYWARD, Calif., Dec. 14, 2010 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal auto-immune responses and inflammation, has selected the Merck BioManufacturing Network in the UK, to manufacture the large scale GMP clinical and pre-commercial supplies of A-623, an investigational novel peptibody in development for a number of autoimmune diseases. "Establishing a rapid and high...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.